Literature DB >> 32919824

Use of Contrast-Enhanced Ultrasound to Determine Thoracic Duct Patency.

Erika J Mejia1, Hansel J Otero2, Christopher L Smith2, Molly Shipman2, Mandi Liu2, Erin Pinto2, Aaron DeWitt2, Jonathan J Rome2, Yoav Dori2, David M Biko2.   

Abstract

The aim of this study was to determine the feasibility of using contrast-enhanced ultrasound (CEUS) evaluation to determine thoracic duct (TD) outlet patency. Nine patients referred for lymphatic imaging and intervention underwent percutaneous intranodal ultrasound contrast injection and conventional lymphangiography (CL). Eight of 9 patients had a patent TD by CEUS and CL. One patient did not have a patent TD. There was 100% agreement between CEUS and CL. These results suggest that CEUS is an imaging modality that might be as accurate as CL in determining TD patency.
Copyright © 2020 SIR. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32919824      PMCID: PMC9361865          DOI: 10.1016/j.jvir.2020.05.022

Source DB:  PubMed          Journal:  J Vasc Interv Radiol        ISSN: 1051-0443            Impact factor:   3.682


  15 in total

1.  Decompression of thoracic duct: new approach for the treatment of failing Fontan.

Authors:  Viktor Hraška
Journal:  Ann Thorac Surg       Date:  2013-08       Impact factor: 4.330

Review 2.  Novel Lymphatic Imaging Techniques.

Authors:  Yoav Dori
Journal:  Tech Vasc Interv Radiol       Date:  2016-10-06

3.  Dynamic contrast-enhanced MR lymphangiography: feasibility study in swine.

Authors:  Yoav Dori; Menekhem M Zviman; Maxim Itkin
Journal:  Radiology       Date:  2014-07-01       Impact factor: 11.105

4.  Thoracic Duct Decompression for Protein-Losing Enteropathy in Failing Fontan Circulation.

Authors:  Marta António; Andreia Gordo; Conceição Pereira; Fátima Pinto; Isabel Fragata; José Fragata
Journal:  Ann Thorac Surg       Date:  2016-06       Impact factor: 4.330

Review 5.  Modern Techniques of Lymphangiography and Interventions: Current Status and Future Development.

Authors:  Maxim Itkin; Gregory J Nadolski
Journal:  Cardiovasc Intervent Radiol       Date:  2017-12-18       Impact factor: 2.740

6.  Management of Cardiac Involvement Associated With Neuromuscular Diseases: A Scientific Statement From the American Heart Association.

Authors:  Brian Feingold; William T Mahle; Scott Auerbach; Paula Clemens; Andrea A Domenighetti; John L Jefferies; Daniel P Judge; Ashwin K Lal; Larry W Markham; W James Parks; Takeshi Tsuda; Paul J Wang; Shi-Joon Yoo
Journal:  Circulation       Date:  2017-08-24       Impact factor: 29.690

7.  MR lymphangiography at 3.0 T: correlation with lymphoscintigraphy.

Authors:  Mike Notohamiprodjo; Mayo Weiss; Ruediger G Baumeister; Wieland H Sommer; Andreas Helck; Alexander Crispin; Maximilian F Reiser; Karin A Herrmann
Journal:  Radiology       Date:  2012-04-20       Impact factor: 11.105

8.  Successful treatment of plastic bronchitis by selective lymphatic embolization in a Fontan patient.

Authors:  Yoav Dori; Marc S Keller; Jack Rychik; Maxim Itkin
Journal:  Pediatrics       Date:  2014-07-07       Impact factor: 7.124

9.  Lymphoscintigraphy patterns in newborns and children with congenital lymphatic dysplasia.

Authors:  C Bellini; G Villa; G Sambuceti; C Traggiai; C Campisi; T Bellini; G Morcaldi; D Massocco; E Bonioli; F Boccardo
Journal:  Lymphology       Date:  2014-03       Impact factor: 1.286

Review 10.  MR Lymphangiography in Children: Technique and Potential Applications.

Authors:  Govind B Chavhan; Joao G Amaral; Michael Temple; Maxim Itkin
Journal:  Radiographics       Date:  2017-10       Impact factor: 5.333

View more
  2 in total

Review 1.  Emerging contrast-enhanced ultrasound applications in children.

Authors:  Ryne A Didier; David M Biko; Misun Hwang; Sunil Unnikrishnan; Magdalena M Woźniak; Gibran T Yusuf; Anush Sridharan
Journal:  Pediatr Radiol       Date:  2021-04-01

Review 2.  Lymphatic Disorders in Patients With Single Ventricle Heart Disease.

Authors:  Yoav Dori; Christopher L Smith
Journal:  Front Pediatr       Date:  2022-06-10       Impact factor: 3.569

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.